Efficacy of Total Thoracoscopic Lobectomy in the Treatment of Early Non-small Cell Lung Cancer
Objective To explore the efficacy of total thoracoscopic lobectomy in the treatment of early non-small cell lung cancer.Methods Clinical data of 76 patients with early non-small cell lung cancer admitted to Shanxian Central Hospital from January 2021 to January 2023 were retrospectively selected and divided into study group and control group according to surgical methods,with 38 cases in each group.Total thoracoscopic lobectomy was performed in the study group,while routine thoracotomy was performed in the control group.The therapeutic effect,operation time,in-traoperative blood loss,drainage tube retention time,hospital stay and complication rate of the two groups were com-pared.Results The effective rate of the study group was 94.73%,higher than that of the control group(78.95%),and the difference was statistically significant(χ2=4.146,P=0.042).The operation time,intraoperative blood loss,drainage tube retention time and hospital stay of the study group were better than those of the control group,and the differences were statistically significant(all P<0.05).The complication rate of the study group was 2.63%,lower than that of the control group(15.79%),and the difference was statistically significant(P<0.05).Conclusion For patients with early non-small cell lung cancer,total thoracoscopic lobectomy can effectively improve the therapeutic effect and improve the pain of patients.
Total thoracoscopePulmonary lobectomyEarly stageNon-small cell lung cancer
万方数据
维普
